1050 related articles for article (PubMed ID: 25056374)
21. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
[TBL] [Abstract][Full Text] [Related]
22. Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma.
Salama AM; Momeni-Boroujeni A; Vanderbilt C; Ladanyi M; Soslow R
Mod Pathol; 2022 Feb; 35(2):274-282. PubMed ID: 34650187
[TBL] [Abstract][Full Text] [Related]
23. Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors.
Wood O; Woo J; Seumois G; Savelyeva N; McCann KJ; Singh D; Jones T; Peel L; Breen MS; Ward M; Garrido Martin E; Sanchez-Elsner T; Thomas G; Vijayanand P; Woelk CH; King E; Ottensmeier C;
Oncotarget; 2016 Aug; 7(35):56781-56797. PubMed ID: 27462861
[TBL] [Abstract][Full Text] [Related]
24. Integrative Genomics and Transcriptomics Analysis Reveals Potential Mechanisms for Favorable Prognosis of Patients with HPV-Positive Head and Neck Carcinomas.
Zhang W; Edwards A; Fang Z; Flemington EK; Zhang K
Sci Rep; 2016 Apr; 6():24927. PubMed ID: 27108969
[TBL] [Abstract][Full Text] [Related]
25. Prevention of tumor growth driven by PIK3CA and HPV oncogenes by targeting mTOR signaling with metformin in oral squamous carcinomas expressing OCT3.
Madera D; Vitale-Cross L; Martin D; Schneider A; Molinolo AA; Gangane N; Carey TE; McHugh JB; Komarck CM; Walline HM; William WN; Seethala RR; Ferris RL; Gutkind JS
Cancer Prev Res (Phila); 2015 Mar; 8(3):197-207. PubMed ID: 25681087
[TBL] [Abstract][Full Text] [Related]
26. Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma.
Troy JD; Weissfeld JL; Youk AO; Thomas S; Wang L; Grandis JR
Head Neck Pathol; 2013 Dec; 7(4):344-55. PubMed ID: 23645351
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
Nazha B; Zhuang T; Wu S; Brown JT; Magee D; Carthon BC; Kucuk O; Nabhan C; Barata PC; Heath EI; Ryan CJ; McKay RR; Master VA; Bilen MA
Cancer; 2023 Dec; 129(24):3884-3893. PubMed ID: 37565840
[TBL] [Abstract][Full Text] [Related]
28. Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3.
Weberpals JI; Lo B; Duciaume MM; Spaans JN; Clancy AA; Dimitroulakos J; Goss GD; Sekhon HS
Clin Cancer Res; 2017 Aug; 23(15):4501-4510. PubMed ID: 28377483
[No Abstract] [Full Text] [Related]
29. LncRNAs as an intermediate in HPV16 promoting myeloid-derived suppressor cell recruitment of head and neck squamous cell carcinoma.
Ma X; Sheng S; Wu J; Jiang Y; Gao X; Cen X; Wu J; Wang S; Tang Y; Tang Y; Liang X
Oncotarget; 2017 Jun; 8(26):42061-42075. PubMed ID: 28159935
[TBL] [Abstract][Full Text] [Related]
30. Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC).
Saba NF; Dinasarapu AR; Magliocca KR; Dwivedi B; Seby S; Qin ZS; Patel M; Griffith CC; Wang X; El-Deiry M; Steuer CE; Kowalski J; Shin DM; Zwick ME; Chen ZG
PLoS One; 2020; 15(9):e0238497. PubMed ID: 32986729
[TBL] [Abstract][Full Text] [Related]
31. HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas.
Rautava J; Kuuskoski J; Syrjänen K; Grenman R; Syrjänen S
J Clin Virol; 2012 Feb; 53(2):116-20. PubMed ID: 22177275
[TBL] [Abstract][Full Text] [Related]
32. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
33. Deciphering head and neck cancer microenvironment: Single-cell and spatial transcriptomics reveals human papillomavirus-associated differences.
Lee H; Park S; Yun JH; Seo C; Ahn JM; Cha HY; Shin YS; Park HR; Lee D; Roh J; Heo HJ; Baek SE; Kim EK; Lee HS; Kim CH; Kim YH; Jang JY
J Med Virol; 2024 Jan; 96(1):e29386. PubMed ID: 38235919
[TBL] [Abstract][Full Text] [Related]
34. High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV.
Walline HM; Carey TE; Goudsmit CM; Bellile EL; D'Souza G; Peterson LA; McHugh JB; Pai SI; Lee JJ; Shin DM; Ferris RL;
Mol Cancer Res; 2017 Feb; 15(2):179-188. PubMed ID: 27899422
[TBL] [Abstract][Full Text] [Related]
35. IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer.
Dale OT; Aleksic T; Shah KA; Han C; Mehanna H; Rapozo DC; Sheard JD; Goodyear P; Upile NS; Robinson M; Jones TM; Winter S; Macaulay VM
Carcinogenesis; 2015 Jun; 36(6):648-55. PubMed ID: 25896444
[TBL] [Abstract][Full Text] [Related]
36. Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models.
Facompre ND; Rajagopalan P; Sahu V; Pearson AT; Montone KT; James CD; Gleber-Netto FO; Weinstein GS; Jalaly J; Lin A; Rustgi AK; Nakagawa H; Califano JA; Pickering CR; White EA; Windle BE; Morgan IM; Cohen RB; Gimotty PA; Basu D
Int J Cancer; 2020 Dec; 147(11):3236-3249. PubMed ID: 32478869
[TBL] [Abstract][Full Text] [Related]
37. HPV-positive clinically advanced squamous cell carcinoma of the urinary bladder (aBSCC): A comprehensive genomic profiling (CGP) study.
Ghelani GH; Zerdan MB; Jacob J; Spiess PE; Li R; Necchi A; Grivas P; Kamat A; Danziger N; Lin D; Huang R; Decker B; Sokol ES; Cheng L; Pavlick D; Ross JS; Bratslavsky G; Basnet A
Urol Oncol; 2023 Dec; 41(12):486.e15-486.e23. PubMed ID: 37821306
[TBL] [Abstract][Full Text] [Related]
38. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
[TBL] [Abstract][Full Text] [Related]
39. Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.
Suda T; Hama T; Kondo S; Yuza Y; Yoshikawa M; Urashima M; Kato T; Moriyama H
BMC Cancer; 2012 Sep; 12():416. PubMed ID: 22994622
[TBL] [Abstract][Full Text] [Related]
40. Novel insight into mutational landscape of head and neck squamous cell carcinoma.
Gaykalova DA; Mambo E; Choudhary A; Houghton J; Buddavarapu K; Sanford T; Darden W; Adai A; Hadd A; Latham G; Danilova LV; Bishop J; Li RJ; Westra WH; Hennessey P; Koch WM; Ochs MF; Califano JA; Sun W
PLoS One; 2014; 9(3):e93102. PubMed ID: 24667986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]